[IEEE-bhpjobs] Fwd: Apr 11 MedTech Forum

Fri Apr 6 07:55:02 EDT 2007

-----Original Message-----
From: Esther Lumsdon [mailto:lumsdon at us.ibm.com]
Sent: Thursday, April 5, 2007 04:13 PM
To: esther-l at mailsnare.net
Subject: Apr 11 MedTech Forum

 Event: 'Medical Tech Forum: Venture Capital & Medical Devices'             

   CED-Research Triangle                                                   
   Council for Entrepreneurial Development                                 

Date: Wednesday, April 11, 2007 At 05:00 PM
Duration: 3 Hours

 Contact Info:            Email: asmith at cednc.org                          
 Adam Smith               URL: http://www.cednc.org                        

http://www.cednc.org/calendar/calendar.php

CED and NCMD are partnering to provide the Medical Tech Forum: Venture
Capital & Medical Devices

Date: April 11, 2007
Time: 5:30 - 8:00 pm (5-5:30 on-site registration; 7:00-8:00 networking
reception)
Location: MCNC Auditorium, 3021 Cornwallis Road, RTP, NC 27709
Fees: CED and NCMD Members $20; Non-members $30
Register: https://secure.cednc.org/my_ced/index.php/event/1729
Directions: http://www.cednc.org/about/directions/mcnc.html

Medical devices and related technology have become an increasingly hot
sector for venture capital investors in recent years. According to
PricewaterhouseCoopers' MoneyTree Report, investments in medical devices
rose over $500M dollars nationally from 2005. In fact, the medical device
sector made up 12% of all dollars invested nationally in 2006, which was
one of its highest percentages ever. In North Carolina, $71M was invested
in the medical device sector in 2006, or roughly 15% of all dollars
invested in the state.

What is making the medical device sector so attractive? What trends will we
see in the coming years? Don’t miss the April 11 MedTech Forum, which will
feature Bill Starling, Chief Executive Officer of Synecor, LLC.

Synecor (www.synecor.com) is a business generator of new Life Science
companies based in Research Triangle Park (RTP), North Carolina, Santa
Rosa, California, and Portola Valley, California. Synecor has significant
academic, scientific, physician, venture capital, corporate, and investment
banking partnerships and is focusing its efforts on the identification and
development of proprietary, disruptive technologies with extraordinary
market potential in the life sciences field.

As CEO of Synecor, Starling is a cofounder of BaroSense, Inc., Bioerodible
Vascular Solutions, Inc., (acquired by Guidant/Abbott in April 2004),
InnerPulse, Inc. (formerly Interventional Rhythm Management, Inc.), and
TransEnterix, Inc., the initial four companies founded and incubated by
Synecor. Starling currently serves as Chairman of the Board for BaroSense,
Inc., a Menlo Park, CA - based obesity company, InnerPulse Inc., a RTP, NC
- based cardiac rhythm management company, and CEO of TransEnterix, Inc., a
RTP, NC - based less invasive GI Surgery company.

He began his 29-year career in the medical technology device industry at
American Edwards Laboratories (Edwards LifeSciences). He was subsequently
part of the founding management team and Director of Marketing for Advanced
Cardiovascular Systems, Inc. (acquired by Guidant/Abbott), and was a
cofounder, Vice President and Board member of Ventritex, Inc. (acquired by
St. Jude Medical). In 1992, Starling was a cofounder and Chairman of the
Board of Directors and President/CEO of Cardiac Pathways Corporation
(acquired by Boston Scientific Corporation), and was responsible for
raising significant capital from the early venture capital period through
an initial public offering in 1996.

Starling has been primarily responsible for raising over $275 million in
private and public capital for the companies that he has co-founded and the
combined revenues of these companies exceeds $1 billion annually. In
addition to the companies that he has co-founded, Starling has made private
investments in the initial equity financings of over 40 startup companies
and has served/is a Board member in over 20 early stage life science
companies. Starling also serves as an independent, outside Director of
AMI-Semiconductor, Inc. (NASDAQ:AMIS), a key vendor for InnerPulse, Inc.

Register today for the April 11th MedTech Forum at:
https://secure.cednc.org/my_ced/index.php/event/1729

-- -- --
Esther Lumsdon, RAC, CQA, Lumsdon at us.ibm.com
IBM Software Test Contractor - SCORE
Local 919-543-8717 (3-8717)
-------------- next part --------------
A non-text attachment was scrubbed...
Name: 16504700.gif
Type: image/gif
Size: 43 bytes
Desc: not available
Url : http://rtpnet.org/pipermail/ieee-bhpjobs/attachments/20070406/e9d1dbd4/attachment.gif 